{"pmid":32251726,"title":"The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good.","text":["The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good.","Pharmacol Res","Gray, Paul E","Belessis, Yvonne","32251726"],"journal":"Pharmacol Res","authors":["Gray, Paul E","Belessis, Yvonne"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251726","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.phrs.2020.104776","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352136305475584,"score":7.6679378,"similar":[{"pmid":32251725,"title":"Reply to \"The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good\".","text":["Reply to \"The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good\".","Pharmacol Res","Zhang, Ai-Hua","Ren, Jun-Ling","Wang, Xi-Jun","32251725"],"journal":"Pharmacol Res","authors":["Zhang, Ai-Hua","Ren, Jun-Ling","Wang, Xi-Jun"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251725","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.phrs.2020.104775","source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352136309669888,"score":87.84552},{"pmid":32245701,"title":"Is traditional Chinese medicine useful in the treatment of COVID-19?","text":["Is traditional Chinese medicine useful in the treatment of COVID-19?","Am J Emerg Med","Zhang, Kai","32245701"],"journal":"Am J Emerg Med","authors":["Zhang, Kai"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245701","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ajem.2020.03.046","keywords":["COVID-19","Comment","Traditional Chinese medicine"],"source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352135868219393,"score":52.370056},{"pmid":32145402,"title":"Traditional Chinese medicine for COVID-19 treatment.","text":["Traditional Chinese medicine for COVID-19 treatment.","Pharmacol Res","Ren, Jun-Ling","Zhang, Ai-Hua","Wang, Xi-Jun","32145402"],"journal":"Pharmacol Res","authors":["Ren, Jun-Ling","Zhang, Ai-Hua","Wang, Xi-Jun"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32145402","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.phrs.2020.104743","link_erratum_in":"32222346","source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352134165331968,"score":44.469505},{"pmid":32170559,"title":"Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan.","text":["Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan.","In December 2019, an outbreak of novel Coronavirus (2019-nCoV) occurred in Wuhan, Hubei Province, China. By February 14, 2020, it has led to 66 492 confirmed patients in China and high mortality up to approximately 2.96% (1123/37 914) in Wuhan. Here we report the first family case of coronavirus disease 2019 (COVID-19) confirmed in Wuhan and treated using the combination of western medicine and Chinese traditional patent medicine Shuanghuanglian oral liquid (SHL). This report describes the identification, diagnosis, clinical course, and management of three cases from a family, suggests the expected therapeutic effects of SHL on COVID-19, and warrants further clinical trials.","Front Med","Ni, Li","Zhou, Ling","Zhou, Min","Zhao, Jianping","Wang, Dao Wen","32170559"],"abstract":["In December 2019, an outbreak of novel Coronavirus (2019-nCoV) occurred in Wuhan, Hubei Province, China. By February 14, 2020, it has led to 66 492 confirmed patients in China and high mortality up to approximately 2.96% (1123/37 914) in Wuhan. Here we report the first family case of coronavirus disease 2019 (COVID-19) confirmed in Wuhan and treated using the combination of western medicine and Chinese traditional patent medicine Shuanghuanglian oral liquid (SHL). This report describes the identification, diagnosis, clinical course, and management of three cases from a family, suggests the expected therapeutic effects of SHL on COVID-19, and warrants further clinical trials."],"journal":"Front Med","authors":["Ni, Li","Zhou, Ling","Zhou, Min","Zhao, Jianping","Wang, Dao Wen"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32170559","week":"202011|Mar 09 - Mar 15","doi":"10.1007/s11684-020-0757-x","keywords":["COVID-19","Chinese traditional patent medicine","Shuanghuanglian oral liquid","novel coronavirus (2019-nCoV)"],"source":"PubMed","locations":["Shuanghuanglian","Chinese","China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663352133972393984,"score":40.113922}]}